EP1073437A4 - Treatment of generalized anxiety disorder with paroxetine - Google Patents

Treatment of generalized anxiety disorder with paroxetine

Info

Publication number
EP1073437A4
EP1073437A4 EP99921431A EP99921431A EP1073437A4 EP 1073437 A4 EP1073437 A4 EP 1073437A4 EP 99921431 A EP99921431 A EP 99921431A EP 99921431 A EP99921431 A EP 99921431A EP 1073437 A4 EP1073437 A4 EP 1073437A4
Authority
EP
European Patent Office
Prior art keywords
paroxetine
treatment
anxiety disorder
generalized anxiety
generalized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99921431A
Other languages
German (de)
French (fr)
Other versions
EP1073437A1 (en
Inventor
Rocco Zaninelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1073437A1 publication Critical patent/EP1073437A1/en
Publication of EP1073437A4 publication Critical patent/EP1073437A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP99921431A 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine Withdrawn EP1073437A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9808479.1A GB9808479D0 (en) 1998-04-22 1998-04-22 Method of treatment
GB9808479 1998-04-22
PCT/US1999/008786 WO1999053919A1 (en) 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine

Publications (2)

Publication Number Publication Date
EP1073437A1 EP1073437A1 (en) 2001-02-07
EP1073437A4 true EP1073437A4 (en) 2003-04-16

Family

ID=10830715

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99921431A Withdrawn EP1073437A4 (en) 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine

Country Status (20)

Country Link
EP (1) EP1073437A4 (en)
JP (1) JP2002512189A (en)
KR (1) KR20010034817A (en)
CN (1) CN1298301A (en)
AP (1) AP2000001959A0 (en)
AU (1) AU3864899A (en)
BG (1) BG104939A (en)
BR (1) BR9909791A (en)
CA (1) CA2328896A1 (en)
CZ (1) CZ20003885A3 (en)
EA (1) EA200001088A1 (en)
GB (1) GB9808479D0 (en)
HU (1) HUP0101350A3 (en)
ID (1) ID27546A (en)
IL (1) IL139167A0 (en)
NO (1) NO20005286L (en)
PL (1) PL343494A1 (en)
SK (1) SK15672000A3 (en)
TR (1) TR200003082T2 (en)
WO (1) WO1999053919A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550A (en) * 1995-02-06 1996-08-07 Smithkline Beecham Plc Forms of paroxetine hydrochloride
WO1997003670A1 (en) * 1995-07-20 1997-02-06 Smithkline Beecham P.L.C. Paroxetine controlled release compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550A (en) * 1995-02-06 1996-08-07 Smithkline Beecham Plc Forms of paroxetine hydrochloride
WO1997003670A1 (en) * 1995-07-20 1997-02-06 Smithkline Beecham P.L.C. Paroxetine controlled release compositions

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ALLGULANDER CHRISTER ET AL: "Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder.", PSYCHOPHARMACOLOGY BULLETIN, vol. 34, no. 2, 1998, pages 165 - 166, XP008013522, ISSN: 0048-5764 *
CASACALENDA N ET AL: "Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.", CANADIAN JOURNAL OF PSYCHIATRY. REVUE CANADIENNE DE PSYCHIATRIE. CANADA SEP 1998, vol. 43, no. 7, September 1998 (1998-09-01), pages 722 - 730, XP008013523, ISSN: 0706-7437 *
IANCU IULIAN ET AL: "Anxiety disorders in the elderly: Treatment considerations.", INTERNATIONAL ACADEMY FOR BIOMEDICAL AND DRUG RESEARCH, vol. 13, 1998, disorders in the elderly: New Therapeutic approaches. 1998 S. Karger AG; S. Karger AG P.O. Box, Allschwilerstrasse 10, CH-4009 Basel, Switzerland; New York, New York, USA, pages 51 - 61, XP008013521, ISBN: 3-8055-6536-4 *
ISAAC M: "WHERE ARE WE GOING WITH SSRIS?", EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, vol. 9, no. SUPPL 3, 1999, pages S101 - S106, XP000881160, ISSN: 0924-977X *
RAVIZZA LUIGI ET AL: "Antidepressant use in generalized anxiety disorder.", INTERNATIONAL ACADEMY FOR BIOMEDICAL AND DRUG RESEARCH, vol. 12, 1997, therapeutic indications of antidepressants. 1997 S. Karger AG; S. Karger AG P.O. Box, Allschwilerstrasse 10, CH-4009 Basel, Switzerland; New York, New York, USA, pages 41 - 48, XP008013519, ISBN: 3-8055-6436-8 *
ROCCA P ET AL: "Paroxetine efficacy in the treatment of generalized anxiety disorder.", ACTA PSYCHIATRICA SCANDINAVICA, vol. 95, no. 5, 1997, pages 444 - 450, XP008013520, ISSN: 0001-690X *
See also references of WO9953919A1 *

Also Published As

Publication number Publication date
CN1298301A (en) 2001-06-06
BG104939A (en) 2001-09-28
ID27546A (en) 2001-04-12
CA2328896A1 (en) 1999-10-28
BR9909791A (en) 2000-12-26
EP1073437A1 (en) 2001-02-07
JP2002512189A (en) 2002-04-23
NO20005286D0 (en) 2000-10-20
PL343494A1 (en) 2001-08-27
WO1999053919A1 (en) 1999-10-28
SK15672000A3 (en) 2001-04-09
TR200003082T2 (en) 2001-01-22
KR20010034817A (en) 2001-04-25
GB9808479D0 (en) 1998-06-17
NO20005286L (en) 2000-12-20
HUP0101350A3 (en) 2002-06-28
EA200001088A1 (en) 2001-04-23
AU3864899A (en) 1999-11-08
HUP0101350A2 (en) 2002-05-29
IL139167A0 (en) 2001-11-25
AP2000001959A0 (en) 2000-12-31
CZ20003885A3 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
EP1200086A4 (en) Methods for treating or preventing pain and anxiety
GB2337763B (en) Methods of treating preform elements
HK1047693A1 (en) Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof
IL134718A0 (en) Treatment of conduct disorder
EP0996433A4 (en) Methods for treatment of conditions associated with lactosylceramide
GB9905275D0 (en) Treatment of conditions associated with membrane-bound receptors and their function
EP1071339A4 (en) Treatment of animals with dihydroxyquinoline compounds
EP1187604A4 (en) Compounds and methods for the treatment of post traumatic stress disorder
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
IL140540A0 (en) Treatment of anxiety disorders
HUP0101350A3 (en) Treatment of generalized anxiety disorder with paroxetine
IL126681A0 (en) Treatment of trauma-related conditions
IL149533A0 (en) Treatment of sle with dehydropiandrosterone
PL345261A1 (en) Method of treatment
HU9904062D0 (en) Fixing rail with holes and process for making of fixing rail
GB2365419B (en) Treatment of effluents
GB9917590D0 (en) Treatment of fibres
GB9819800D0 (en) Treatment of fibres
GB9818295D0 (en) Treatment of alopecia
GB9822681D0 (en) Method of treatment
SI1117403T1 (en) Mglur5 antagonists for the treatment of pain and anxiety
GB9822458D0 (en) Methods of treatment
GB9824208D0 (en) Methods of treatment
DK82798A (en) Treatment of GABA-uptake related disorders
UA33583A (en) METHOD OF THERAPY OF SIMPLE SCHIZOPHRENIA

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001017

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: RO PAYMENT 20001017;SI PAYMENT 20001017

A4 Supplementary search report drawn up and despatched

Effective date: 20030303

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030528

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1034201

Country of ref document: HK